Background and Purpose-T2*-weighted gradient-echo MRI is known to detect old microbleeds (MBs), considered indicative of microangiopathy. MBs might be a potential risk factor for early cerebral bleeding (CB) after ischemic stroke. Therefore, we assessed the impact of MBs on the occurrence of CB after cerebral infarction. Methods-We included prospectively stroke patients who had documented ischemic damage. The imaging protocol involved baseline CT scan, T2*-weighted gradient-echo MRI, diffusion-weighted imaging, T2-weighted imaging, and magnetic resonance angiography and had to be performed within 24 hours after symptom onset. The assessment of CB with T2*-weighted gradient-echo sequence necessitated a focal area of signal loss either within the ischemic area revealed by diffusion-weighted imaging or remote from it. Old MBs were defined on T2*-weighted images as homogeneous rounded areas of signal loss without surrounding edema. CT scan was systematically repeated within the first week to verify CB as diagnosed by the T2* weighted sequence. Results-One hundred patients (mean age, 60Ϯ13 years; range, 19 to 83 years; 58 men, 42 women) met the inclusion criteria. MBs were seen in 20 patients on T2*-weighted imaging. Multivariate logistic regression analysis revealed that age, diabetes, previous use of antithrombotic drugs, evidence of an atherothrombotic source of stroke, and lacunar infarct were significantly associated with MBs (PϽ0.0001). CB was diagnosed in 26 patients: at the acute stage by T2*-gradient echo sequence in 18 patients and with CT scan performed within the first week in 8 patients. Multivariate logistic regression analysis showed that baseline National Institutes of Health Stroke Scale score, diabetes, and MBs were considered significant and independent predictors of CB (PϽ0.001). Conclusions-Although the pathogenesis of CB after ischemic stroke is multifactorial, the increased observation of CB in patients with MBs suggests that the associated vascular vulnerability contributes to CB. 
A pproximately 20% to 40% of all stroke patients experience hemorrhagic transformation within the first week after symptom onset. 1 Although cerebral bleeding (CB) is a common event that occurs independently of therapy, 2 caution is required when thrombolysis 3, 4 or anticoagulants 5 are administered.
The identification of risk factors for CB might be helpful in improving the risk-to-benefit ratio of thrombolytic treatments. 6 -9 Hypertension, embolic origin, use of anticoagulant therapy, increasing stroke severity, and duration and intensity of the cerebral blood flow reduction have been associated with a higher risk of CB. 10 -13 New MRI techniques may also identify patients at increased risk of subsequent intracranial hemorrhage. 14 A higher sensitivity of MRI to hyperacute hemorrhage [15] [16] [17] [18] lasting Ͻ12 hours has been demonstrated when T2*-weighted sequences are used. Moreover, T2*-weighted sequences have the potential to reveal old intracranial bleeding in a substantial proportion of patients with primary lobar hemorrhage 19, 20 and less frequently in patients with ischemic stroke. 21 These microbleeds (MBs) are thought to be indicative of microangiopathy. MBs are also considered as a marker of amyloid angiopathy. 22 The likelihood of early CB after ischemic stroke might be increased in patients who had the most vulnerable microvascular system. 23 MRI demonstration of MBs could gain even more clinical significance if this finding could be used to identify patients at increased risk of early CB. Therefore, we assessed the impact of this abnormality on the occurrence of CB.
Patients and Methods
We included prospectively ischemic stroke patients whose symptoms lasted Ͼ1 hour and who had documented ischemic damage.
Figure 1.
A 43-year-old woman developed an acute severe left hemiplegia. A, Baseline CT scan performed 2 hours 15 minutes after symptom onset showed early signs of ischemia within right MCA territory (attenuation of right lenticular nucleus). B, T2*-weighted gradient-echo sequences performed 15 minutes later (2 hours 30 minutes after symptom onset) revealed an area of deep right MCA territory of signal loss within right lenticular nuclei. C, T2*-weighted gradient-echo sequences at day 1 (17 hours after symptom onset) showed a larger area of signal loss within lenticulostriate arteries territory. D, CT scan performed 10 minutes after MRI confirmed the hemorrhagic transformation within this area.
Stroke onset was defined as the last time the patient was known to be free of deficit. All patients were examined acutely by a stroke attending physician. The NIH Stroke Scale (NIHSS) score 24 was recorded by a clinician certified in the administration of the scale at the time of baseline CT imaging and was repeated on day 7.
The multisequence MRI protocol included at least diffusionweighted imaging (DWI), T2-weighted imaging, T2*-weighted gradient echo, and magnetic resonance angiography and had to be performed as a single session within 24 hours after symptom onset. Patients with unstable vital signs or general MRI contraindications were excluded from the MRI study. Informed consent was required from all patients or their next of kin. Patients were included in the analysis if they had a readable MRI.
Antithrombotic drugs were given according to the suspected mechanism of stroke and current therapeutical management in use at our institution. When tissue plasminogen activator (tPA) was given, MRI was performed after thrombolysis to avoid excessive delay to treatment. Other antithrombotic drugs were administered after either the CT scan or MRI if the latter was obtained immediately after the CT scan. Acute neurological worsening led to an immediate CT scan. CB was considered spontaneous if the patient did not receive any antithrombotic drugs before MRI. CBs were categorized into 4 different subtypes according to the Second European Cooperative Acute Stroke Study (ECASSII) criteria. 8 In addition to the pure radiological definition, the category of symptomatic hemorrhage was used for patients with clinical deterioration of Ն4 points on the NIHSS and with no CT findings that might have been responsible for this deterioration other than a hemorrhage. Neurovascular workup included analysis of risk factors, including history of hypertension, diabetes mellitus, hyperlipidemia, smoking habit, stroke or TIA, cardiac disease, previous use of antithrombotic agents, and search for an arterial or cardiac source of embolism with neck ultrasound, ECG, and echocardiography. The Trial of Org 10172 in Acute Stroke treatment (TOAST) criteria were used to classify stroke type. 25 
Imaging Data Acquisition
MRI was performed with a superconductive unit operating at 1.5 T (Siemens AG, Medical Group) that used a circular polarized head coil equipped with enhanced gradient hardware for echo-planar imaging. The MRI procedure included 3 sequences. First was a dual fast spin-echo T2 sequence with an echo time (TE) of 16 to 98 ms, repetition time (TR) of 3000 ms, 20 axial slices, thickness of 5 mm, distance factor of 0.20, asymmetric matrix of nϫ512, field of view of 250 mm, and acquisition time of 5 minutes. Second was an axial isotropic DWI spin-echo echo-planar imaging sequence with a TR of 4.700 ms, TE of 118 ms, 20 axial slices, thickness of 5 mm, matrix of 128ϫ128, field of view of 260 mm, 1 excitation, and an acquisition time of 23 seconds. Two b values were used (0 and 1000 s/mm 2 ) in the vision system. The DWI sequence at bϭ1.000 was run 3 times with diffusion gradients applied in each of the x, y, and z directions. The third sequence was a T2*-weighted gradient-echo sequence with a TR of 800 ms, TE of 26 ms, flip angle of 20°, thickness of 5 mm, 20 axial slices, distance factor of 0.20, asymmetric matrix of nϫ256, 2 excitations, acquisition time of 6 minutes, and a field of view of 250 mm. The final sequence was a 3DTOF turbo magnetic resonance angiography with a TR of 35 ms, TE of 6.4 ms, flip angle of 20°, asymmetric matrix of nϫ512, field of view of 240 mm, 1 excitation, and an acquisition time of 6 minutes 44 Figure 2 . A 74-year-old man developed an acute left hemiplegia. MRI was performed 7 hours after symptom onset. A, Spin-echo T2-weighted imaging showed periventricular and deep white matter damage and multiple lacunes. B, Gradient-echo T2*-weighted imaging revealed multiple areas of signal loss consistent with old MBs. C, DWI showed a recent ischemic area within right corona radiata appropriate for symptoms (arrow). seconds, with 3 axial slabs (thickness, 31.9 mm; partitions, 24; distance factor, 0.38) placed over the entire circle of Willis. The scanning time for the whole MRI protocol was Ϸ20 minutes with an additional 10 minutes for patient positioning.
The analysis involved 4 stages. In the first step, assessment of CB with T2*-weighted gradient-echo sequences necessitated a focal area of signal loss consistent with bleeding either within the ischemic area revealed by DWI or remote from the ischemic damage ( Figure 1 ). Second, MBs were defined on T2*-weighted images as homogeneous rounded areas of signal loss of 2 to 5 mm in diameter without surrounding edema ( Figure 2 ). An area of symmetric hypointensity of the globus pallidus, likely to represent calcification, and loss of signal in the distal middle cerebral artery (MCA) and its branches seen in the sylvian fissure consistent with calcified atheromatous plaque or acute thrombosis (MCA dot sign) 26 were disregarded. Third, the severity of a white matter hyperintense area on T2-weighted images ( Figure 2 ) was graded according to the method of Fazekas and colleagues. 27 Finally, lacunes were categorized as areas (Ͻ10 mm in diameter) isointense to cerebrospinal fluid and hyperintense on T2-weighted sequences (Figure 2 ). 28 Baseline CT scan was performed with a fourth-generation CT (Elscint CT Twin). Thrombolytic therapy monitoring in our protocol included a follow-up CT scan at days 1 and 7 as previously described. 29 A repeated CT scan within the first week was required for patients who received other antithrombotic drugs. CT scans and MRI were reviewed by 2 neuroradiologists without knowledge of clinical data and treatment assignment (M.H., J.C.F.) whose consensus determined the MRI and CT findings.
Statistical Analysis
Logistic regression analysis was used to assess (1) the relationship between MBs with the variables age, sex, hypertension, diabetes, hyperlipidemia, smoking, previous stroke, cardioembolic and athero- 
Results

Patients
Between January 2000 and May 2001, 100 patients (mean age, 60Ϯ13 years; range, 19 to 83 years; 58 men, 42 women) met the inclusion criteria. During this same period, 810 patients were evaluated by the inpatient Lyon Stroke Service, and 572 subsequently received the diagnosis of acute ischemic stroke. Among the 100 patients, 53% had hypertension, 33% had hypercholesterolemia, 19% had diabetes, 47% were smokers, 26% had a history of transient ischemic attack or minor stroke, and 27% were long-term users of antithrombotic drugs. Stroke involved anterior circulation in 60 patients and posterior circulation in 40 patients. Mean baseline NIHSS score was 10Ϯ6.3. CT scan was performed 4Ϯ4 hours (median, 3 hours) and MRI was done 10Ϯ7 hours (median, 9 hours) after stroke onset. Twenty-seven patients received tPA before MRI assessment, whereas 73 patients were given other antithrombotic agents-58 were treated before MRI and 15 after MRI. Eight patients received antiplatelet agents (aspirin, thienoperidin), 39 received efficient anticoagulant therapy (heparin infusion or warfarin), and 26 had subcutaneous lowmolecular-weight heparin (Nadroparin 0.3 mL, once or twice daily). Stroke was attributed to large-artery atherosclerosis in 37 patients, cardioembolic source in 30, small-vessel disease in 15, arterial dissection in 4, and unknown origin in 14.
Imaging Data
Old MBs MBs were seen in 20 patients exclusively on T2*-weighted imaging. MBs were found in 9 patients who had MRI before therapy and in 11 patients who had MRI after treatment initiation. No significant difference was recorded between groups (Pϭ0.80; CI, Ϫ0.14 to 0.18). Most patients with MBs exhibited multiple lesions, which were located mainly in cortical-subcortical regions and basal ganglia. Univariate logistic regression analysis (Table 1) showed that patients with MBs were significantly older, hypertensive, and diabetic and had significantly more lacunar infarcts and atherothrombotic source of stroke. MBs were also more frequent in patients who were long-term antithrombotic users. Multivariate logistic regression analysis (Table 2 ) revealed that age, diabetes, previous use of antithrombotic drugs, evidence of an atherothrombotic source of stroke, and lacunar infarct were significantly associated with MBs.
Early CB CB was diagnosed in 26 patients at the acute stage by T2*-weighted gradient-echo sequence in 18 patients and with CT scan performed within the first week in 8 patients. Suspected bleeding on T2*-weighted gradient-echo sequence was confirmed by follow-up CT. Bleeding was observed within the ischemic area (nϭ24) and remote from it (nϭ2). CB was defined as hemorrhagic infarction (nϭ21; type 1, nϭ13; type 2, nϭ8) and parenchymal hemorrhage (nϭ5; type 1, nϭ2; type 2, nϭ3). Clinical deterioration was related to parenchymal hemorrhage type 2 (nϭ3) defined as dense hematoma of Ͼ30% of the infarcted area. Death occurred in 6 patients and was caused by either the progression of brain ischemia (nϭ5) or recurrent stroke (n ϭ1). Univariate logistic regression analysis (Table 3) showed that patients who experienced CB were older, more often were hypertensive and diabetic, and more frequently had lacunes and MBs (Old MBs were detected in 10 patients who had CB). No significant difference in CB rate was observed between the different therapeutic groups, even after adjustment for all variables (Pϭ0.7). CB occurred in 16 patients who had therapy before MRI and in 10 patients who were treated after MRI. A significant difference in bleeding rate was recorded between groups (Pϭ0.002; CI, 0.03 to 0.38), thus suggesting a possible role of antithrombotic drugs. Multivariate logistic regression analysis (Table 4) showed that baseline NIHSS score, diabetes, and more clearly MBs were considered significant and independent predictors of CB.
Discussion
CB can be a devastating complication of ischemic stroke and the main adverse effect of thrombolytic treatment. 7, 8, 30, 31 Conventional MRI often fails to detect CB at 
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the early stage of stroke. As a result, CT scan remains the standard diagnostic test for identification of CB during this period. New MRI techniques provide critical information in detecting acute bleeding. [15] [16] [17] [18] As blood extravasates in the tissue, the hemoglobin molecule becomes deoxygenated. Deoxyhemoglobin thereby produces a nonuniform magnetic field that results in rapid dephasing of proton spins in T2-and more so in T2*-weighted images. To the best of our knowledge, this study is the earliest evaluation of acute CB with T2*-weighted imaging in a large cohort of ischemic stroke patients. Our results confirm the usefulness of T2*-weighted gradient-echo sequence in detecting early hemorrhage transformation as part of a multimodal stroke MRI protocol. The mechanism of CB remains a remarkably complex and dynamic process involving a combination of microvascular injury with altered permeability and reperfusion integrated over time. 23, 32, 33 The spectrum of CB differs widely and may include some trivial hemorrhagic petechiae or parenchymal hemorrhage with space-occupying effect with an increased risk of clinical worsening. As previously described, 34, 35 clinical deterioration was related to parenchymal hemorrhage type 2 (nϭ3) defined as dense hematoma of Ͼ30% of the infarcted area Brain microvasculature is potentially weakened by such factors as increasing age, sustained exposure to elevated blood pressure, hyperglycemia, and amyloid or fibrohyalinosis degeneration of brain blood vessels. Old MBs provide further evidence of severe microangiopathy with a subsequent increased vascular vulnerability.
Roob et al 36 used gradient-echo MRI to detect small hemosiderin deposits in 280 people without clinical neurological disease. MBs were found in 6% of these individuals and were associated with advancing age, hypertension, and leukoariosis. Histological examination of MR foci of signal loss has detected moderate to severe fibrohyalinosis, suggesting that lacunar hemorrhages are related to bleeding-prone microangiopathy. [37] [38] [39] The rate of hemosiderin deposits was in the range of previous study using T2*-weighted gradient-echo sequence 21 In line with current data, we found a significant association between the presence of MBs and other morphological signs of cerebral microangiopathy. The association of long-term use of antithrombotic agents was also significantly linked to the presence of MBs
The risk of intracerebral hemorrhage after secondary prevention with oral anticoagulants seems higher in patients anticoagulated after a nondisabling ischemic stroke than after myocardial infarction. 40 Leukoariosis and lacunar state of the basal ganglia are frequently observed in patients who experienced intracranial hemorrhage under warfarin therapy. Both abnormalities have been suggested to indicate a higher risk of bleeding. 41 However, in these CT scan studies, the rate of MBs underlying the lacunar aspect could not be assessed. According to our data, old MBs might also be involved in the group of known risk factors favoring CB after brain ischemia. However, several limitations must be considered. The rate of hemorrhage transformation might have been underestimated because the infarcts could have become hemorrhagic later and thus were not seen on follow-up CT scan. Although most secondary hemorrhages occur within the second week after ischemic stroke, 42 unfavorable outcomes are usually expected within the early period, when the assessment of bleeding by T2* MRI might influence stroke management. Other possible causes of areas of hypointensity such as a cavernous hemangioma may have been assessed as old lacunar hemorrhage. Moreover, because of the small sample size of each therapeutic group, our study did not have the statistical power to demonstrate the hemorrhagic effect of a particular treatment. Conversely, a global hemorrhagic effect can be anticipated from the subgroup analysis of patients who had MRI after treatment.
Owing to the saturation of our MR unit (a single machine for an 865-bed third-referral center), only 100 patients of 572 stroke subjects could be included at the acute stage. Moreover, a total of 27% received recombinant tPA; this high frequency was related to our recruitment procedure that focused on early admission consistent with the use of recombinant tPA. Accordingly, it is conceivable that this sample might be not representative of the whole stroke population, thus hampering interpretation of these data Although the pathogenesis of CB is multifactorial, the relationship between acute CB and previous vessel wall damage as revealed by the presence of MBs suggests an increased vascular vulnerability. However, larger numbers of patients in general and those with MBs in particular are needed to clearly established this relation. Although the results of the analysis comparing the rate of MBs between patients who had MRI before and after treatment were not significant, the distinction between hemosiderin deposits and more recent bleedings needs a preposttreatment T2*-weighted MRI assessment. However, because the benefit of antithrombotic agents outweighs the hemorrhagic risk in randomized clinical trials, further research is needed to examine the risk-to-benefit ratio of antithrombotics in a subgroup at risk of both thrombotic and hemorrhagic event. For this purpose, the use of MRI as baseline imaging modality is warranted. 
